Featured Editorial

  1. Integrating QMS And eTMF For Proactive Clinical Trial Quality 6/24/2025

    In today’s clinical trial landscape, where complexity is the new challenge, integration is not optional: QMS defines quality, and eTMF proves it. 

  2. How Is RIM Software Transforming Regulatory Compliance? 6/20/2025

    Regulatory information management (RIM) software tools streamline global regulatory processes on a single cloud-based platform throughout the entire product life cycle.

  3. What Sponsors Should Know About The Remote Patient Monitoring (RPM) Market 5/16/2025

    MarketsandMarkets consultant Tushar Genji details the current remote patient monitoring (RPM) market.

  4. The Risks Of AI In Clinical Research From A Trial Management Perspective 4/9/2025

    In part two of this series, consultant Donatella Ballerini explores the challenges of integrating AI into eTMF management and how to mitigate them.

  5. How AI Models Can Actually Improve eTMF Management 4/8/2025

    GCP consultant Donatella Ballerini explores how AI is shaping eTMF management and what this means for the future of clinical research in part one of this series.

  6. eClinical Solutions Market To Double In 5 Years, As Sponsors Prioritize Efficiency 4/4/2025

    The global eClinical solutions market is projected to reach $22.1 billion in 2029, double its presence in 2024. Experts discuss the specific solutions driving market growth and share how they impact clinical operations.

  7. Is Double Programming Really Required For Validation? 3/10/2025

    Double programming has been the gold standard for validation, but technological advancements and improved sponsor oversight of CRO deliverables have introduced more efficient and reliable alternatives.

  8. Why Is Trust Stifling Our RBM Implementations? 3/6/2025

    It’s one thing to implement RBM (risk-based monitoring) components like central monitoring or initial risk assessments, but if you’re still doing 100% SDR/SDV, you’re not maximizing the benefits of this approach. So what’s the holdup?

  9. Pros & Cons Of Using Wearables In Clinical Trials 2/26/2025

    What are the biggest advantages and challenges of using wearables in a clinical trial? And who do you need on your team to add wearables to a trial? These are the questions Bryan Hansen, Ph.D. of Johnson & Johnson Innovative Medicine answers in this Q&A.

  10. Wearables: An Essential For Decentralized Clinical Trials 2/20/2025

    Bryan Hansen, Ph.D., director of Innovative Health at Johnson & Johnson Innovative Medicine, discusses types of wearables, his experience using them in neurological disease clinical trials, and some future plans for these devices.